Declerck YA - Search Results

1

Interleukin-6 in bone metastasis and cancer progression.

Ara T, Declerck YA. Ara T, et al. Among authors: declerck ya. Eur J Cancer. 2010 May;46(7):1223-31. doi: 10.1016/j.ejca.2010.02.026. Epub 2010 Mar 23. Eur J Cancer. 2010. PMID: 20335016 Free PMC article. Review.

2

Protease inhibitors: role and potential therapeutic use in human cancer.

DeClerck YA, Imren S. DeClerck YA, et al. Eur J Cancer. 1994;30A(14):2170-80. doi: 10.1016/0959-8049(94)00460-m. Eur J Cancer. 1994. PMID: 7857719 Review.

3

Proteases and protease inhibitors in tumor progression.

DeClerck YA, Imren S, Montgomery AM, Mueller BM, Reisfeld RA, Laug WE. DeClerck YA, et al. Adv Exp Med Biol. 1997;425:89-97. doi: 10.1007/978-1-4615-5391-5_9. Adv Exp Med Biol. 1997. PMID: 9433492 Review.

4

The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis.

Sugiura Y, Ma L, Sun B, Shimada H, Laug WE, Seeger RC, DeClerck YA. Sugiura Y, et al. Among authors: declerck ya. Cancer Res. 1999 Mar 15;59(6):1327-36. Cancer Res. 1999. PMID: 10096567

5

Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer.

DeClerck YA. DeClerck YA. Eur J Cancer. 2000 Jun;36(10):1258-68. doi: 10.1016/s0959-8049(00)00094-0. Eur J Cancer. 2000. PMID: 10882864 Review.

6

Lytic bone lesions in human neuroblastoma xenograft involve osteoclast recruitment and are inhibited by bisphosphonate.

Sohara Y, Shimada H, Scadeng M, Pollack H, Yamada S, Ye W, Reynolds CP, DeClerck YA. Sohara Y, et al. Among authors: declerck ya. Cancer Res. 2003 Jun 15;63(12):3026-31. Cancer Res. 2003. PMID: 12810621

7

Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment.

Chantrain CF, Shimada H, Jodele S, Groshen S, Ye W, Shalinsky DR, Werb Z, Coussens LM, DeClerck YA. Chantrain CF, et al. Among authors: declerck ya. Cancer Res. 2004 Mar 1;64(5):1675-86. doi: 10.1158/0008-5472.can-03-0160. Cancer Res. 2004. PMID: 14996727

8

Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells.

Sohara Y, Shimada H, Minkin C, Erdreich-Epstein A, Nolta JA, DeClerck YA. Sohara Y, et al. Among authors: declerck ya. Cancer Res. 2005 Feb 15;65(4):1129-35. doi: 10.1158/0008-5472.CAN-04-2853. Cancer Res. 2005. PMID: 15734993

9

The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent.

Jodele S, Chantrain CF, Blavier L, Lutzko C, Crooks GM, Shimada H, Coussens LM, Declerck YA. Jodele S, et al. Among authors: declerck ya. Cancer Res. 2005 Apr 15;65(8):3200-8. doi: 10.1158/0008-5472.CAN-04-3770. Cancer Res. 2005. PMID: 15833851

10

Mechanisms of bone invasion and metastasis in human neuroblastoma.

Sohara Y, Shimada H, DeClerck YA. Sohara Y, et al. Among authors: declerck ya. Cancer Lett. 2005 Oct 18;228(1-2):203-9. doi: 10.1016/j.canlet.2005.01.059. Cancer Lett. 2005. PMID: 15975706 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters